MYB-fusions and other potential actionable targets in adenoid cystic carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference42 articles.
1. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality;Fordice;Arch Otolaryngol Head Neck Surg,1999
2. Distant metastasis in adenoid cystic carcinoma of salivary origin;Spiro;Am J Surg,1997
3. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies;Airoldi;Cancer,2001
4. Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients;Licitra;Ann Oncol,1996
5. Whole exome sequencing of adenoid cystic carcinoma;Stephens;J Clin Invest,2013
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma;FEBS Letters;2023-12-27
2. Current Approach to Undifferentiated Neoplasms, With Focus on New Developments and Novel Immunohistochemical Stains;ARCH PATHOL LAB MED;2023
3. Extracting Potential New Targets for Treatment of Adenoid Cystic Carcinoma using Bioinformatic Methods;IRAN BIOMED J;2023
4. Extracting Potential New Targets for Treatment of Adenoid Cystic Carcinoma using Bioinformatic Methods;Iranian Biomedical Journal;2023-09-01
5. Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma;Journal of Clinical Oncology;2023-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3